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Introduction: Dynamic retinal vessel analysis (DVA) is a new non-invasive method to
quantify microvascular endothelial dysfunction by flicker light-induced dilatation (FID).
FID has been shown to be impaired in type 2 diabetes as well as heart failure. The
aim of the study was to analyze FID in healthy active versus healthy sedentary and
cardiovascular (CV) risk patients in addition to corresponding static vessel diameters.
Methods: Thirty-one healthy active (HA, mean age 60  8 years), 33 healthy sedentary
individuals (HS, 59  7 years) and 76 sedentary patients with increased CV risk (SR,
58  6 years) were included in this cross-sectional study. Group differences in CV risk
factors and cardiorespiratory fitness, maximal arteriolar (ADmax) and venular (VDmax)
dilatation as well as the arteriolar (AFarea) and venular (VFarea) area under the flicker
curve were analyzed. The central retinal arteriolar and venular diameters were used to
calculate the arteriolar-to-venular diameter ratio (AVR).
Results: HS [ADmax = 3.5 (2.1)%; AFarea = 48.2 (31.9)%s] showed higher FID
compared to SR [ADmax = 2.7 (1.8)%, p = 0.021; AFarea = 34.5 (26.5)%s, p = 0.006]
and HA [AFarea = 32.8 (23.1)%s, p = 0.029]. HA and SR did not significantly differ. HA
had a higher AVR (0.87  0.05) compared to HS (0.83  0.04, p < 0.001) with further
deterioration in SR (0.79  0.05, p < 0.001). Interestingly, 28 participants had impaired
FID but normal AVR and 43 participants had normal FID but impaired AVR.
Discussion: FID can differentiate between sedentary low and high risk individuals.
However, FID in healthy active persons (HA) seemed impaired with a concomitant
higher AVR. We postulate that lower FID in HA may be explained by predilatated
arterioles and a reduced dilatation reserve. We recommend combination of FID with
analysis of retinal vessel diameters to differentiate functional non-responders from
manifest microvascular endothelial dysfunction and, thereby, improve microvascular risk
stratification in a personalized medicine approach.
Clinical Trial Registration: ClinicalTrials.gov: NCT02796976 (https://clinicaltrials.gov/
ct2/show/NCT02796976).
Keywords: microcirculation, flicker light-induced dilatation, retinal vessel diameters, physical activity,
cardiovascular disease
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INTRODUCTION
Dynamic retinal vessel analysis is a new non-invasive diagnostic
tool to assess microvascular endothelial dysfunction. Flicker
light-induced dilatation (FID) of arterioles seem to reflect
cardiovascular (CV) risk at a subclinical stage. Nägele et al.
showed that FID is reduced in patients with CV risk factors
compared to healthy controls with further deterioration in
heart failure patients (Nagele et al., 2018b). Sörensen et al.
(2016) demonstrated reduced FID in patients with prediabetes
compared to healthy individuals with further impairments in
patients with manifest type 2 diabetes (Sörensen et al., 2016).
Impaired FID has also been associated with hypertension
(Machalinska et al., 2018), hypercholesterolemia (Nagele et al.,
2018a), obesity (Kotliar et al., 2011) and higher age (Kneser et al.,
2009). With respect to static retinal vessel diameters, narrower
arterioles, wider venules and a resulting lower arterio-venous
ratio (AVR) have been associated with incidence hypertension
(Wang et al., 2003; Wong et al., 2004; Ikram et al., 2006b),
stroke (Ikram et al., 2006a; McGeechan et al., 2009) and
a higher CV morbidity and mortality (Wang et al., 2007;
Seidelmann et al., 2016). No studies to date have combined
dynamic and static retinal vessel analysis in an individual patient-
orientated approach.
Physical inactivity is a major risk factor for development
of non-communicable chronic diseases such as CV disease.
Lower physical activity (PA) is associated with a higher CV
mortality (Handschin and Spiegelman, 2008). Blair et al. (1995)
demonstrated a mortality risk reduction of 44% in individuals
who improved their lifestyle from unfit to fit compared to
participants who remained unfit (Blair et al., 1995). Moderate
PA of 90 min per week has been associated with a reduction of
all-cause mortality by 14% (Wen et al., 2011). Age and physical
fitness are known to affect microvascular function. Bioavailability
of nitric oxide (NO), a key modulator of endothelial function,
is higher in young physically active individuals compared to
sedentary controls and has been associated with improved
microvascular endothelial function in the skin (Franzoni et al.,
2004). Favorable retinal vessel diameters have previously been
associated with higher PA and fitness (Anuradha et al., 2011;
Hanssen et al., 2011; Streese et al., 2019). To date, no data
are available on the association of PA and fitness with retinal
microvascular endothelial function in healthy individuals and in
patients with CV disease.
The aims of the study were twofold. We aimed to compare FID
in healthy active (HA) with healthy sedentary (HS) individuals
to determine the impact of lifelong PA on retinal endothelial
function. Moreover, we aimed to compare HS with sedentary
individuals at increased CV risk (SR) to determine the impact
Abbreviations: ACmax, maximal arteriolar constriction; ADmax, maximal
arteriolar dilatation; AFarea, arteriolar area under the flicker curve; AVR,
arteriolar-to-venular diameter ratio; DVA, dynamic retinal vessel analysis; FID,
flicker light-induced dilatation; FQPA, Freiburg Questionnaire of physical activity;
HA, healthy active individuals; HS, healthy sedentary individuals; NO, nitric
oxide; PA, physical activity; SR, sedentary patients with increased cardiovascular
risk; VCmax, maximal venular constriction; VDmax, maximal venular dilatation;
VFarea, venular area under the flicker curve.
of CV risk factors on FID. We hypothesized that HA would
have aggravated FID whereas SR would present with a blunted
microvascular response. Our study, for the first time, aimed to
report individual retinal FID in relation to the corresponding
vessel diameters by combining dynamic and static retinal
vessel analysis.
MATERIALS AND METHODS
Design and Study Population
Participants from the EXAMIN AGE cohort (Streese et al.,
2018) were recruited from January 2016 till December 2017
through local sports and running clubs, advertisements in local
newspapers in and around the city of Basel and through
our Outpatient Prevention Clinic. All participants signed a
written informed consent before the first measurement at
the Department of Sport, Exercise and Health in Basel,
Switzerland took place. Anthropometric measurements and
retinal vessel analysis were performed in the morning under
fasting conditions. This study was approved through the Ethics
Committee of Northwest and Central Switzerland (EKNZ 2015-
351) and conducted according to the Helsinki Declaration
(World Medical Association, 2013). The study is registered at
ClinicalTrials.gov (NCT02796976).
Inclusion and Exclusion Criteria
Men and women aged 50–80 years were included in the study.
Inclusion criteria for HA was an active lifestyle [>9 metabolic
equivalents (METs)/week]. Inclusion criteria for HS and SR was
a sedentary lifestyle (3 METs/week). Additionally, SR needed to
have at least 2 CV risk factors as described in Figure 1A.
Exclusion criteria for HA and HS were any risk factor
described in Figure 1A, macular degeneration, glaucoma or any
eye disease or history of CV, pulmonary or chronic inflammatory
diseases. Exclusion criteria for patients with increased CV risk
were chronic eye disease, decompensated cardiopulmonary or
chronic inflammatory disease and/or restricting orthopedic
problems. Two sport scientists independently allocated
participants to the active or sedentary groups or to exclude
the subject on mutual grounds on the basis of PA history,
self-reported freiburg questionnaire of physical activity (FQPA),
accelerometer data and maximal oxygen uptake (VO2max).
Retinal Vessel Analysis
After pupil dilatation of the right eye (in 16 patients the left
eye was measured due to local eye problems) with Tropicamide
0.5% SDU Faure (THEA Pharma, Schaffhausen, Switzerland)
and 10 min of rest, retinal endothelial function was measured
using the retinal vessel analyzer system (IMEDOS; GmbH, Jena,
Germany) and a fundus camera (FF450; Carl Zeiss GmbH,
Jena, Germany). The measurements took place in a quiet, dark
and temperature-controlled room (20–22C). To reduce eye
movements and to measure the region of interest, a fixation
needle was used. One straight arteriolar and venular segment
in the upper temporal quadrant, one optic disk diameter away
from the optic disk edge were marked. Diameters of these
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FIGURE 1 | Cardiovascular risk factors (A) and flow-chart (B).
segments were continuously recorded for 350 s. The first 50 s
(baseline) were followed by three cycles of 20 s flicker light
(flicker frequency 12.5 Hz) followed by 80 s of recovery (green
light without flicker). Based on the raw data we averaged
the flicker cycles to calculate maximal arteriolar (ADmax) and
venular (VDmax) flicker response, maximal arteriolar (ACmax)
and venular (ACmax) constriction as well as the integral under
the arteriolar (AFarea) and venular (VFarea) flicker curve. In
order to improve the data quality, two experienced scientists
independently judged the quality of every raw signal as previously
described (Kotliar et al., 2017). Only raw signals with sufficient
quality were included in the final analysis (Figure 1B). Al-Fiadh
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previously reported an interclass correlation coefficient of 0.82
for the arteriolar dilatation using the same flicker protocol (Al-
Fiadh et al., 2014). AVR was calculated from central retinal
arteriolar (CRAE) and central retinal venular (CRVE) equivalents
which were measured as previously described (Hanssen et al.,
2011) using the Paar-Hubbard formula (Hubbard et al., 1999).
Previous studies indicate that ADmax values below 2.5%
(Al-Fiadh et al., 2015; Sörensen et al., 2016; Nagele et al.,
2018b) as well as lower AVR values in the range of <0.82
(Wong et al., 2004; Ikram et al., 2006a) are associated with
increased CV risk.
Anthropometry, Physical Fitness and
Activity
All anthropometry measurements were performed as described
in our published study protocol (Streese et al., 2018). Blood
pressure (BP) was measured in a 24 h monitoring and twice
before the microvascular assessments after 10 min of rest.
Cardiorespiratory fitness including VO2max and maximal heart
rate (HRmax) was measured according a treadmill ramp protocol
as previously recommended (Bader et al., 1999; Myers and
Bellin, 2000; Streese et al., 2018) using the Cortex Metalyzer
R 3B metabolic test system (Cortex Biophysik GmbH, Leipzig,
Germany). Participants wore an Aipermotion 440 accelerometer
(Aipermon GmbH, Munich, Germany) on their left hip
for six consecutive days to evaluate daily PA. Total steps
per day and minutes of walking per day were calculated
from the five most active days using AiperView 440 and
ActiCoach MPAT2Viewer Software (Aipermon GmbH, Munich,
Germany) (Jehn et al., 2009a,b). Additionally, participants
reported total sports activities using the FQPA (Frey et al.,
1999). The intensity in this questionnaire is represented
in METs based on the updated Ainsworth Compendium
(Ainsworth et al., 2011). Based on the available data we
calculated the PROCAM Score as previously recommended
(Assmann et al., 2002).
Statistical Analysis and Sample Size
Calculation
We characterized our cohort by reporting baseline characteristics
as mean and standard deviation (SD). Group effects were
analyzed by using a one-way ANOVA with a 2-sided 95%-
confidence interval or Mann–Whitney-U-Test if no normal
distribution was assumed. Data distribution was analyzed
graphically. Turkey HSD tests were used to differentiate group
effects. Linear regression models were used to calculate a
potential association between ADmax and AVR, ADmax, and
AFarea, as well as to calculate the influence of classical risk factors
on arteriolar FID. The graphs were generated in Excel 2016 and
RStudio. All statistical tests were performed with RStudio, version
1.1.463 (R Development Core Team, 2008).
To date, no study on PA and retinal endothelial function exists.
Therefore, we calculated the sample size based on our previous
study where we investigated static retinal vessel diameter in three
different groups with a total sample size of 45 participants. AVR
differentiated between obese runners, lean amateur and elite
runners (Hanssen et al., 2011). Based on an expected slightly
higher variability for DVA, we conservatively planned to include
30 participants in each group to detect group differences with
ADmax as the main outcome.
RESULTS
Population Characteristics
Thirty-one HA (mean age 60  8 years, 45% female), 33
HS (mean age 59  7 years, 69% female) and 76 SR
(mean age 58  6 years, 51% female) were included in the
final analysis (Figure 1B). Distribution of CV risk factors
in SR is shown in Figure 1A. Population characteristics are
presented in Tables 1–4.
Retinal Microvascular Function
Healthy sedentary showed higher FID compared to SR [HS:
ADmax = 3.5 (2.1)%; AFarea = 48.2 (31.9)%s vs. SR:
ADmax = 2.7 (1.8)%, p = 0.021; AFarea = 34.5 (26.5)%s,
p = 0.006] and HA [HA: AFarea = 32.8 (23.1)%s, p = 0.029]
(Figure 2 and Table 3). FID in HA and SR did not significantly
differ (Figure 2 and Table 4). Median flicker response calculated
separately for every second and group is shown in Figure 3.
We found little evidence for other group differences in ADmax,
AFarea, VDmax, and VFarea (Tables 1–4). Higher age was
significantly associated with reduced ADmax and AFarea. No
significant associations were observed for body mass index
(BMI), 24 h systolic and diastolic blood pressure, fasting glucose,
high-density lipoprotein (HDL), low-density lipoprotein (LDL),
triglyceride, PA or fitness. However, patients with diabetic
medications or elevated fasting glucose levels (n = 32) showed
reduced ADmax [2.3 (1.7)% vs. 3.2 (1.8)%, p = 0.092] and
significantly blunted AFarea [24.7 (23.1)%s vs. 41.7 (26.7)%s,
p = 0.031] compared to non-diabetic SR (n = 44). Other risk
factors were not associated with FID. No gender-specific group
differences were observed.
HA showed a higher AVR compared to HS with a further
decline in SR (0.87  0.05 vs. 0.83  0.04 vs. 0.79  0.05,
p < 0.001). Mean AVR in our cohort was 0.82. Of the 84
participants who had an AVR < 0.82, 39 had ADmax values
<2.5% and 43 individuals>2.5%. Of the 58 participants who had
an AVR > 0.82, 28 had ADmax values <2.5% and 30 individuals
>2.5% (Figure 4).
Linear regression model between ADmax and AVR showed
no statistically significant association [r(138) = 0.013,
p = 0.093]. ADmax and AFarea were highly correlated
[r(138) = 39.35; p< 0.001].
DISCUSSION
Arteriolar FID can differentiate between HS and at risk (SR)
individuals with better retinal endothelial function in healthy
individuals. However, several individuals in the HA group
seemed to present with impaired FID, which was accompanied
by a higher AVR. AVR was higher in HA compared to
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TABLE 1 | Overall population characteristics.
HA (n = 31) mean (SD) HS (n = 33) mean (SD) SR (n = 76) mean (SD) p
Population characteristics
Sex (f/m) 14/17 23/10 39/37 0.137
Age (years) 60 .8/ 59 .7/ 58 .6/ 0.286
Height (cm) 171 .7/ 168 .9/ 169 .8/ 0.390
Weight (kg) 63:9 .5:9/ 70:8 .9:9/ 94:8 .13:9/ <0.001
BMI (kg/m2) 21:9 .1:6/ 24:9 .2:5/ 33:2 .4:1/ <0.001
WC (cm) 82:0 .6:6/ 90:1 .8:9/ 111:2 .11:6/ <0.001
Fat mass (kg) 12:4 .3:8/ 22:8 .5:7/ 38:0 .9:7/ <0.001
Muscle mass (kg) 28:5 .4:2/ 26:2 .4:7/ 31:6 .7:0/ <0.001
Rest systolic BP (mmHg) 127 .16/ 128 .15/ 132 .14/ 0.165
Rest diastolic BP (mmHg) 77 .8/ 81 .8/ 88 .9/ <0.001
24 h. systolic BP (mmHg) 120 .7/ 121 .7/ 130 .11/ <0.001
24 h. diastolic BP (mmHg) 76 .5/ 76 .6/ 81 .8/ <0.001
Fasting glucose (mmol/l) 4:7 .0:4/ 4:7 .0:5/ 5:8 .1:9/ <0.001
Triglyceride (mmol/l) 1:0 .0:3/ 1:1 .0:3/ 1:8 .1:1/ <0.001
HDL (mmol/l) 1:9 .0:4/ 1:7 .0:4/ 1:3 .0:3/ <0.001
LDL (mmol/l) 2:8 .0:8/ 3:2 .0:8/ 3:1 .0:8/ 0.183
PROCAM Score 28:2 .6:5/ 32:6 .9:6/ 41:3 .9:3/ <0.001
Activity and fitness
FQPA (METS) 44:7 .33:3/ 1:9 .2:3/ 1:0 .2:1/ <0.001
Steps per day (n) 12492 .4230/ 10298 .3914/ 8697 .3591/ <0.001
Walking per day (min) 142 .49/ 124 .45/ 105 .43/ <0.001
VO2max (ml O2/min) 43:3 .8:7/ 29:8 .4:2/ 26:1 .4:2/ <0.001
Retinal microcirculation
AVR 0:87 .0:05/ 0:83 .0:04/ 0:79 .0:05/ <0.001
ADmax (%) 2:7 .1:6/ 3:5 .2:1/ 2:7 .1:8/ 0.099
AFarea (%s) 32:8 .23:1/ 48:2 .31:9/ 34:5 .26:5/ 0.037
ACmax (%)  1:4 .1:2/  1:3 .1:2/  1:3 .1:0/ 0.807
VDmax (%) 4:2 .1:8/ 4:0 .2:0/ 4:0 .2:1/ 0.914
VFarea (%s) 41:0 .21:7/ 43:6 .25:7/ 43:4 .24:6/ 0.876
VCmax (%)  0:9 .0:7/  0:8 .0:9/  0:7 .0:6/ 0.266
HA, healthy active; HS, healthy sedentary; SR, sedentary at risk; BMI, body mass index; WC, waist circumference; BP, blood pressure; HDL, high-density lipoprotein;
LDL, low-density lipoprotein; FQPA, Freiburg questionnaire of physical activity; METS, metabolic equivalents; VO2max, maximal oxygen uptake; AVR, arteriolar-to-
venular diameter ratio; ADmax, maximal arteriolar dilatation; AFarea, integral under arteriolar flicker curve; ACmax, maximal arteriolar constriction; VDmax, maximal
venular dilatation; VFarea, integral under venular flicker curve; VCmax, maximal venular constriction; SD, standard deviation; p, level of significance for overall group
differences (ANOVA). Bold values are statistically significant p-values (p < 0.05).
HS with further deterioration in SR. When analyzing the
combination of individual dynamic FID with concomitant static
retinal vessel diameters, we identified patients with impaired
FID but normal AVR and vice versa. Both dynamic FID and
static retinal vessel diameters have previously been shown
to be associated with CV risk and incidence CV disease.
Our current findings pose a diagnostic challenge and need
to be addressed in order to put into perspective the use of
retinal microvascular function as a diagnostic tool for CV
risk stratification.
To date, few data are available on DVA as a new method
to assess retinal microvascular endothelial function in health
and disease. To verify our results, we need to compare our
findings in active and sedentary individuals with previous reports
in individuals with low and high CV risk. In our study,
sedentary healthy individuals showed an ADmax of 3.5%. In
comparison, FID in healthy older individuals, measured by
the same flicker protocol, has been previously described to
be between 3.6% (Nagele et al., 2018b) and 3.8% (Seshadri
et al., 2016), which is in line with our findings. In our study,
HS were explicitly screened for sedentary behavior which is
likely to explain the slightly lower arteriolar FID compared
to previous reports. Sedentary patients with increased CV
risk (SR) had a mean ADmax of 2.7% in our study. This
is comparable to the few previous reports in patients with
CV risk ranging between 2.3% (Nagele et al., 2018b) and
2.4% (Al-Fiadh et al., 2015). The slight difference to previous
reports may be explained by a lower CV risk profile in our
patients. It can therefore be concluded that our findings of FID
in sedentary healthy and diseased individuals stand in good
agreement with the available but scarce literature. No study to
date has investigated the impact of PA and fitness on retinal
endothelial function. Most interestingly, we found a blunted
FID (2.7%) in HA which was comparable to our findings in
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TABLE 2 | Group differences between healthy active and healthy
sedentary individuals.
HA (n = 31)
mean (SD)
HS (n = 33)
mean (SD)
p
Population characteristics
Sex (f/m) 14/17 23/10 0.088
Age (years) 60 .8/ 59 .7/ 0.799
Height (cm) 170 .7/ 168 .9/ 0.204
Weight (kg) 63:9 .5:9/ 70:8 .9:9/ 0.010
BMI (kg/m2) 21:9 .1:6/ 24:9 .2:5/ <0.001
WC (cm) 82:0 .6:6/ 90:1 .8:9/ <0.001
Fat mass (kg) 12:4 .3:8/ 22:8 .5:7/ <0.001
Muscle mass (kg) 28:5 .4:2/ 26:2 .4:7/ 0.076
Rest systolic BP (mmHg) 127 .16/ 128 .15/ 0.882
Rest diastolic BP (mmHg) 77 .8/ 81 .8/ 0.046
24 h. systolic BP (mmHg) 120 .7/ 121 .7/ 0.363
24 h. diastolic BP (mmHg) 76 .5/ 76 .6/ 0.914
Fasting glucose (mmol/l) 4:7 .0:4/ 4:7 .0:5/ 0.680
Triglyceride (mmol/l) 1:0 .0:3/ 1:1 .0:3/ 0.086
HDL (mmol/l) 1:9 .0:4/ 1:7 .0:4/ 0.027
LDL (mmol/l) 2:8 .0:8/ 3:2 .0:8/ 0.111
PROCAM Score 28:2 .6:5/ 32:6 .9:6/ 0.020
Activity and fitness
FQPA (METS) 44:7 .33:3/ 1:9 .2:3/ <0.001
Steps per day (n) 12492 .4230/ 10298 .3914/ 0.100
Walking per day (min) 142 .49/ 124 .45/ 0.212
VO2max (ml O2/min) 43:3 .8:7/ 29:8 .4:2/ <0.001
Retinal microcirculation
AVR 0:87 .0:05/ 0:83 .0:04/ <0.001
ADmax (%) 2:7 .1:6/ 3:5 .2:1/ 0.152#
AFarea (%s) 32:8 .23:1/ 48:2 .31:9/ 0.029#
ACmax (%)  1:4 .1:2/  1:3 .1:2/ 0.611#
VDmax (%) 4:2 .1:8/ 4:0 .2:0/ 0.639#
VFarea (%s) 41:0 .21:7/ 43:6 .25:7/ 0.815#
VCmax (%)  0:9 .0:7/  0:8 .0:9/ 0.059#
HA, healthy active; HS, healthy sedentary; BMI, body mass index; WC, waist
circumference; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; FQPA, Freiburg questionnaire of physical activity; METS, metabolic
equivalents; VO2max, maximal oxygen uptake; AVR, arteriolar-to-venular diameter
ratio; ADmax, maximal arteriolar dilatation; AFarea, integral under arteriolar flicker
curve; ACmax, maximal arteriolar constriction; VDmax, maximal venular dilatation;
VFarea, integral under venular flicker curve; VCmax, maximal venular constriction;
SD, standard deviation; p, level of significance for independent samples t-test or
Mann–Whitney-U-Test#. Bold values are statistically significant p-values (p < 0.05).
sedentary patients at risk (SR; 2.7%). As described before, PA and
fitness are associated with reduced CV mortality and improved
microvascular endothelial function (Blair et al., 1995; Franzoni
et al., 2004; Wen et al., 2011). Why then do HA present
with a blunted FID similar to patients with CV risk in the
SR group?
A previous conference report from the annual meeting of
the Association for Research in Vision and Ophthalmology
in 2007 supports our findings of a reduced FID in active
individuals. Lovasik et al. (2007) investigated arteriolar FID
in ten healthy endurance-trained runners and ten healthy
sedentary controls. Runners showed a reduced arteriolar FID
( 2.3%) (Lovasik et al., 2007) and wider arteriolar diameters
TABLE 3 | Group differences between healthy sedentary and sedentary individuals
with increased CV risk.
HS (n = 33)
mean (SD)
SR (n = 76)
mean (SD)
p
Population characteristics
Sex (f/m) 23/10 39/37 0.037
Age (years) 59 .7/ 58 .6/ 0.452
Height (cm) 168 .9/ 169 .8/ 0.089
Weight (kg) 70:8 .9:9/ 94:8 .13:9/ <0.001
BMI (kg/m2) 24:9 .2:5/ 33:2 .4:1/ <0.001
WC (cm) 90:1 .8:9/ 111:2 .11:6/ <0.001
Fat mass (kg) 22:8 .5:7/ 38:0 .9:7/ <0.001
Muscle mass (kg) 26:2 .4:7/ 31:6 .7:0/ <0.001
Rest systolic BP (mmHg) 128 .15/ 132 .14/ 0.171
Rest diastolic BP (mmHg) 81 .8/ 88 .9/ 0.003
24 h. systolic BP (mmHg) 121 .7/ 130 .11/ 0.002
24 h. diastolic BP (mmHg) 76 .6/ 81 .8/ 0.022
Fasting glucose (mmol/l) 4:7 .0:5/ 5:8 .1:9/ <0.001
Triglyceride (mmol/l) 1:1 .0:3/ 1:8 .1:1/ 0.042
HDL (mmol/l) 1:7 .0:4/ 1:3 .0:3/ <0.001
LDL (mmol/l) 3:2 .0:8/ 3:1 .0:8/ 0.135
PROCAM Score 32:6.9:6/ 41:3 .9:3/ 0.007
Activity and fitness
FQPA (METS) 1:9 .2:3/ 1:0 .2:1/ 0.205
Steps per day (n) 10298 .3914/ 8697 .3591/ 0.138
Walking per day (min) 124 .45/ 105 .43/ 0.174
VO2max (ml O2/min) 29:8 .4:2/ 26:1 .4:2/ <0.001
Retinal microcirculation
AVR 0:83 .0:04/ 0:79 .0:05/ <0.001
ADmax (%) 3:5 .2:1/ 2:7 .1:8/ 0.021#
AFarea (%s) 48:2 .31:9/ 34:5 .26:5/ 0.006#
ACmax (%)  1:3 .1:2/  1:3 .1:0/ 0.412#
VDmax (%) 4:0 .2:0/ 4:0 .2:1/ 0.455#
VFarea (%s) 43:6 .25:7/ 43:4 .24:6/ 0.579#
VCmax (%)  0:8 .0:9/  0:7 .0:6/ 0.820#
HS, healthy sedentary; SR, sedentary at risk; BMI, body mass index; WC, waist
circumference; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; FQPA, Freiburg questionnaire of physical activity; METS, metabolic
equivalents; VO2max, maximal oxygen uptake; AVR, arteriolar-to-venular diameter
ratio; ADmax, maximal arteriolar dilatation; AFarea, integral under arteriolar flicker
curve; ACmax, maximal arteriolar constriction; VDmax, maximal venular dilatation;
VFarea, integral under venular flicker curve; VCmax, maximal venular constriction;
SD, standard deviation; p, level of significance for independent samples t-test or
Mann–Whitney-U-Test#. Bold values are statistically significant p-values (p < 0.05).
(Kergoat et al., 2008) compared to healthy controls. In our
study, HA significantly differed in baseline retinal vessel
diameters compared to SR. HA had a higher AVR compared
to HS with a further decline in SR. It therefore seems
plausible to speculate that the reduced FID in active peers
is a sign of a physiologic adaptation to exercise training,
leading to arteriolar predilatation and a subsequent reduced
dilatation capacity rather than a sign of manifest endothelial
dysfunction. The physiologic importance of baseline diameter
or dilatation status for interpretation of retinal arteriolar
endothelial function has been addressed previously. Neumann
et al. (2016) measured retinal vessel diameters as well as FID
under normal and hypoxic conditions (Neumann et al., 2016).
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TABLE 4 | Group differences between healthy active and sedentary individuals
with increased CV risk.
HA (n = 31)
mean (SD)
SR (n = 76)
mean (SD)
p
Anthropometry data
Sex (f/m) 14/17 39/37 0.572
Age (years) 60 .8/ 58 .6/ 0.315
Height (cm) 171 .7/ 169 .8/ 0.627
Weight (kg) 63:9 .5:9/ 94:8 .13:9/ <0.001
BMI (kg/m2) 21:9 .1:6/ 33:2 .4:1/ <0.001
WC (cm) 82:0 .6:6/ 111:2 .11:6/ <0.001
Fat mass (kg) 12:4 .3:8/ 38:0 .9:7/ <0.001
Muscle mass (kg) 28:5 .4:2/ 31:6 .7:0/ 0.001
Rest systolic BP (mmHg) 127 .16/ 132 .14/ 0.234
Rest diastolic BP (mmHg) 77 .8/ 88 .9/ <0.001
24 h. systolic BP (mmHg) 120 .7/ 130 .11/ 0.001
24 h. diastolic BP (mmHg) 76 .5/ 81 .8/ 0.018
Fasting glucose (mmol/l) 4:7 .0:4/ 5:8 .1:9/ <0.001
Triglyceride (mmol/l) 1:0 .0:3/ 1:8 .1:1/ 0.004
HDL (mmol/l) 1:9 .0:4/ 1:3 .0:3/ <0.001
LDL (mmol/l) 2:8 .0:8/ 3:1 .0:8/ 0.762
PROCAM Score 28:2 .6:5/ 41:3 .9:3/ <0.001
Activity and fitness
FQPA (METS) 44:7 .33:3/ 1:0 .2:1/ <0.001
Steps per day (n) 12492 .4230/ 8697 .3591/ <0.001
Walking per day (min) 142 .49/ 105 .43/ 0.003
VO2max (ml O2/min) 43:3 .8:7/ 26:1 .4:2/ <0.001
Retinal microcirculation
AVR 0:87 .0:05/ 0:79 .0:05/ <0.001
ADmax (%) 2:7 .1:6/ 2:7 .1:8/ 0.318#
AFarea (%s) 32:8 .23:1/ 34:5 .26:5/ 0.264#
ACmax (%)  1:4 .1:2/  1:3 .1:0/ 0.205#
VDmax (%) 4:2 .1:8/ 4:0 .2:1/ 0.247#
VFarea (%s) 41:0 .21:7/ 43:4 .24:6/ 0.898#
VCmax (%)  0:9 .0:7/  0:7 .0:6/ 0.235#
HA, healthy active; SR, sedentary at risk; BMI, body mass index; WC, waist
circumference; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; FQPA, Freiburg questionnaire of physical activity; METS, metabolic
equivalents; VO2max, maximal oxygen uptake; AVR, arteriolar-to-venular diameter
ratio; ADmax, maximal arteriolar dilatation; AFarea, integral under arteriolar flicker
curve; ACmax, maximal arteriolar constriction; VDmax, maximal venular dilatation;
VFarea, integral under venular flicker curve; VCmax, maximal venular constriction;
SD, standard deviation; p, level of significance for independent samples t-test or
Mann–Whitney-U-Test#. Bold values are statistically significant p-values (p < 0.05).
Under hypoxic conditions, retinal arterioles dilated as a
physiologic autoregulatory response to low oxygen partial
pressure. It was shown that FID was blunted after hypoxia-
induced predilatation of the arteriole (Neumann et al., 2016).
It therefore seems plausible that exercise-induced dilatation
of arterioles may lead to a reduced dilatation reserve and
blunted retinal FID.
The following discussion of large artery endothelial function
in athletes aims to support and generalize our hypothesis. It
is well established that endurance training is associated with
peripheral conduit artery remodeling with larger arteries in
the exercised limbs (Schmidt-Trucksass et al., 2000; Huonker
et al., 2003; Rowley et al., 2011). The existence of an
“athlete’s artery” has previously been proposed addressing
the paradox why endothelial function is not enhanced in
long-term trained athletes (Green et al., 2012). Endothelial
function, as measured by flow-mediated dilatation (FMD)
in the brachial artery, has been shown to be increased,
normal or even decreased in athletes, questioning the long-
term effects of exercise on arterial function (Green et al.,
2013; Montero et al., 2013). The mechanisms remain unclear
but the baseline diameter at rest seems to play a key role.
Celermajer et al. (1992) found a strong correlation between
resting arterial diameter and FMD, a direct measure of
endothelial function in the brachial artery (Celermajer et al.,
1992). Narrower arteries had a greater dilatation response
and healthy subjects with large baseline arteries showed a
blunted FMD. These results were confirmed by Rembold
et al. (2003). The correlation between FMD and retinal FID
are low to moderate (Pemp et al., 2009; Nagele et al.,
2018b), nonetheless the underlying mechanisms may indeed be
comparable. Both methods measure shear stress-induced and
NO-mediated vascular dilatation (Corretti et al., 2002; Dorner
et al., 2003) in response to different stimuli. It therefore seems
reasonable to hypothesize that the same physiologic principle of a
reduced dilatation reserve in predilatated large and small arteries
may account for reduced endothelial response in physically active
and fit subjects.
To illustrate the resting diameter, we used AVR and not
CRAE because CRAE has a high inter-individual variability
depending on the magnification factor and the anatomy and
height of the individual. AVR represents the ratio between CRAE
and CRVE which neutralizes these inter-individual differences.
The use of AVR may help put into perspective the role of
the arteriolar baseline diameter and the interpretation of FID
as a vascular biomarker for CV risk. In Figure 4 we plotted
arteriolar FID against the corresponding AVR for all individuals
in our study. Individuals with a high AVR and a coinciding high
FID present with a favorable, healthy microvascular phenotype
(green area), whereas it appears eminent that persons with a
low AVR and a coinciding low FID present with an impaired
microvascular phenotype associated with an increased CV risk
(red area). However, a high fluctuation of arteriolar FID becomes
evident in patients with the same AVR. Several subjects with
a favorably high AVR present with low arteriolar FID. At the
other end of the scale, several subjects with a critically low AVR
present with high FID (gray areas). How can this conundrum
be explained?
Individuals with a high AVR but blunted FID are
predominantly physically active and fit. An exercise-induced
predilatation with a reduced dilatation reserve my lead to the
reduction in FID. Individuals with low AVR but high FID are
predominantly SR. Differences in functional and structural
narrowing of the baseline diameters may help explain this
phenomenon. Patients with narrow arterioles and low AVR
with normal endothelial function are likely to have functional
narrowing of the arterioles, for example due to higher blood
pressure. Increase in blood pressure stimulates myogenic
vasoconstriction (Bayliss effect) and is associated with functional
narrowing of arterioles (Lip and Hall, 2007), which may still
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FIGURE 2 | Arteriolar and venular flicker response in healthy active (HA), healthy sedentary (HS) and sedentary individuals with increased CV risk (SR). ADmax,
maximal arteriolar dilatation; VDmax, maximal venular dilatation; AFarea, integral under arteriolar flicker curve; VFarea, integral under venular flicker curve; p < 0.05
for Mann–Whitney-U-Test.
be reversible. Long-term hypertension may induce structural
remodeling and severe vascular damage. Patients with narrow
arterioles and low AVR as well as impaired endothelial function
are prone to have structural damage, which is less likely to
be reversible. It is of utmost interest for future studies to
investigate whether these patients differ in long-term CV
outcome and prognosis. In our study, no associations of DVA
with classic CV risk factors were found. This does not appear
to be surprising on the basis of the above arguments. Due
to the necessary differentiation of microvascular function
in active and sedentary individuals the mere association of
risk factors with FID may get blurred. The combined use
of static and DVA gives information beyond association
of risk factors.
From a clinical perspective it is necessary to define cut-
off values for both the arteriolar flicker response and retinal
vessel diameters. No such cut-off values have been defined as
yet. However, ADmax values between 2.3 and 2.4% or lower
have been associated with CV risk factors (Al-Fiadh et al., 2015;
Nagele et al., 2018b), diabetes (Sörensen et al., 2016) or
heart failure (Nagele et al., 2018b). Lower AVR values are
associated with hypertension (Ikram et al., 2006b), diabetes
and inflammation (Wong et al., 2006) as well as coronary
heart disease (Wong et al., 2002), stroke (Ikram et al., 2006a)
and a higher CV mortality (Wang et al., 2007) and AVR
levels below the mean of our cohort (0.82) are generally
considered as pathological. We therefore set our intra-cohort
study cut-off levels at a FID of 2.5% and AVR of 0.82.
Definite cut off values need to be defined in future prospective
long-term outcome trials. Moreover, there seems to be an
urgent need for individual differentiation of the physiologic
or pathophysiologic principles underlying retinal microvascular
impairments. In an individualized diagnostic approach, a
healthy active individual should not be diagnosed with retinal
endothelial dysfunction in the presence of a high AVR and
in the absence of CV risk factors. In sedentary patients with
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FIGURE 3 | Median arteriolar flicker response in healthy active (blue), healthy sedentary (yellow) and sedentary individuals with increased CV risk (red).
FIGURE 4 | Maximal arteriolar dilatation in % (ADmax) and arteriolar-to-venular diameter ratio (AVR) of every study participant. HA, healthy active; HS, healthy
sedentary; SR, sedentary patients with increased CV risk.
known CV risk factors, a sustained normal FID is a good
sign, however, a low AVR may indicate functional arteriolar
narrowing and a remaining CV risk. In a population-based
approach with large cohorts these differentiations may be
negligible and may be lost in the statistical deviation. Findings
of previous population-based large cohort studies on associations
of retinal vessel phenotype with CV risk and risk prediction
are very valuable. However, it does not necessarily mean
that these findings can equivalently be transferred into a
personalized medicine approach. The combination of impaired
FID and low AVR are indeed associated with increased
CV risk. But for individual risk stratification and treatment
recommendations, the proposed differentiation of arteriolar
FID in relation to the AVR seems clinically indicated and is
strongly recommendable.
This study has some limitations. Participants in our study were
between 50 and 80 years old. Our findings and interpretation
of results cannot be generalized to other age groups. The
discussion of the results is based on sound physiologic principles
and previous findings. Nonetheless, we are aware that the
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interpretation of our results remains hypothesis-driven. The
discussed physiologic mechanisms need to be confirmed in
future studies which was beyond the scope of our current study
approach. Future research needs to apply patient-orientated
differentiated diagnostics on the retinal microvascular phenotype
in long-term follow up studies to correctly stratify individual risk
and estimate prognosis as well as offer appropriate treatment
recommendations. Our study is cross-sectional and effects of
therapeutic interventions on retinal microvascular phenotype
need to be elucidated. Inclusion criteria for SR were 2 CV
risk factors out of seven. The study was not designed to
discriminate between these CV risk factors. Further research
in larger population-based cohorts is needed to evaluate the
influence of these CV risk factors on the retinal microvascular
function separately.
To conclude, arteriolar FID assessed by DVA differentiates
between low and high CV risk in older adults. Physically
fit individuals show a blunted FID comparable to patients
with CV disease. A possible explanation may be a reduced
dilatation reserve as a result of arteriolar predilatation in
exercise-trained subjects. Our results demonstrate that a
differentiated assessment of retinal endothelial function in
combination with retinal vessel diameters is warranted to
meet the diagnostic challenge of an individualized personal
medicine approach.
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